Efficacy and Effectiveness – What is Good Enough? Who decides?
Friday, December 4, 2009

7a – Los Angeles
9a – Chicago, Lima
10a – NYC
3p – London
4p – Lagos
5p – Johannesburg
8:30p – Delhi
2A – Sydney

Join IRMA, the Global Campaign for Microbicides and the AIDS Vaccine Advocacy Coalition and our panel of distinguished speakers (below) for what is sure to be a provocative and dynamic discussion about efficacy and effectiveness of new prevention technologies – PrEP, male circumcision, vaccines, and microbicides.

What is acceptable to communities in both the developing and developed world? What about behaviour change? How do we balance public health impact vs. the needs of the individual? We won’t be able to answer all of these questions – but we can start the discussion!

Please RSVP today.You must RSVP to receive dial-in information.

Featured speakers include Gus Cairns, Editor, HIV Treatment Update NAM Publications (Aidsmap); Dr Sheila Harvey MDP301 Trial Coordinator, Mwanza, Tanzania; and Dr. Roger Tatoud, Senior Programme Manager, International HIV Clinical Trial Research Management Office, Imperial College London. Representatives from AVAC and GCM will also make comments.

Special thanks to AVAC for hosting the call!

Click here for materials (PowerPoints and recordings) from past IRMA Global Teleconferences.